Ginkgo Bioworks Holdings (DNA) Current Assets (2020 - 2026)

Ginkgo Bioworks Holdings' Current Assets history runs 7 years deep, the most recent figure standing at $410.0 million for Q1 2026.

• Quarterly Current Assets fell 27.38% year-over-year to $410.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $410.0 million (down 27.38% YoY) and the FY2025 annual result came in at $471.8 million, down 21.72% from the prior year.
• Current Assets was $410.0 million for Q1 2026 at Ginkgo Bioworks Holdings, down from $471.8 million in the prior quarter.
• Across five years, Current Assets topped out at $1.7 billion in Q1 2022 and bottomed at $410.0 million in Q1 2026.
• A 5-year average of $961.1 million and a median of $903.0 million in 2024 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2022 — Current Assets surged 165261.75% — and 2024, when it tumbled 41.98%.
• Ginkgo Bioworks Holdings' Current Assets stood at $1.5 billion in 2022, then sank by 30.92% to $1.0 billion in 2023, then tumbled by 39.83% to $602.7 million in 2024, then decreased by 21.72% to $471.8 million in 2025, then dropped by 13.12% to $410.0 million in 2026.
• Business Quant data shows DNA's Current Assets at $410.0 million in Q1 2026, $471.8 million in Q4 2025, and $506.1 million in Q3 2025.